Nasdaq

Labcorp Debuts First FDA-Cleared Blood Test for Alzheimer's, Stock Up

Labcorp Holdings, Inc. LH has announced the nationwide availability of the Lumipulse pTau-217/Beta Amyloid 42 Ratio — the first FDA-cleared blood-based in-vitro diagnostic (IVD) test to assist in ...
The Business Journals

Labcorp to offer first FDA-cleared blood test for initial Alzheimer’s disease assessment

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min As the number of Americans at ...
Benefits Pro

Labcorp to pay $19M to whistleblowers to settle 'blood draw' kickback lawsuit

The complex health care fraud scheme involved billing for medically unnecessary tests and the payment of kickbacks to physicians in exchange for tests ordered by Labcorp, who denies all allegations.
Seeking Alpha

Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease Assessment in Primary Care

BURLINGTON, N.C., Feb. 11, 2026 /PRNewswire/ -- Labcorp (LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide availability of the Elecsys® pTau-181 ...